Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.15B | 1.95B | 1.82B | 1.86B | 1.81B |
Gross Profit | 2.00B | 1.73B | 754.10M | 884.30M | 874.30M |
EBITDA | 1.19B | 988.60M | 865.00M | 1.06B | 1.06B |
Net Income | 264.70M | 126.90M | 204.90M | -56.80M | 453.40M |
Balance Sheet | |||||
Total Assets | 16.77B | 15.65B | 14.53B | 14.44B | 14.18B |
Cash, Cash Equivalents and Short-Term Investments | 1.67B | 1.40B | 340.40M | 240.90M | 744.10M |
Total Debt | 10.79B | 10.00B | 8.44B | 7.98B | 8.45B |
Total Liabilities | 14.77B | 13.60B | 12.02B | 11.48B | 11.15B |
Stockholders Equity | 2.00B | 2.06B | 2.51B | 2.96B | 3.03B |
Cash Flow | |||||
Free Cash Flow | -79.90M | -19.00M | 93.50M | 305.90M | 221.80M |
Operating Cash Flow | 918.10M | 745.10M | 787.50M | 934.40M | 865.80M |
Investing Cash Flow | -987.20M | -731.40M | -593.40M | -639.70M | -555.70M |
Financing Cash Flow | 358.80M | 1.04B | -85.00M | -809.70M | -89.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $16.76B | 8.45 | 25.94% | 2.23% | 30.74% | 143.94% | |
73 Outperform | $10.97B | 16.73 | 9.61% | 3.31% | 20.70% | 14.59% | |
69 Neutral | $27.70B | 24.67 | 10.14% | 2.29% | 13.37% | 13.29% | |
68 Neutral | $2.70B | 19.81 | 8.20% | 2.66% | 0.62% | -24.24% | |
66 Neutral | $2.77B | 22.02 | 12.82% | 2.59% | 8.55% | 13.57% | |
62 Neutral | $10.33B | 30.54 | 13.03% | 4.39% | 11.73% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |